VEGFR2/CD309 antibody (PerCP-Cy5.5)
Quick Overview for VEGFR2/CD309 antibody (PerCP-Cy5.5) (ABIN7278486)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- This monoclonal antibody was purified from tissue culture supernatant via affinity chromatography. The purified antibody was conjugated under optimal conditions, with unreacted dye removed from the preparation. It is recommended to store the product undiluted at 4°C, and protected from prolonged exposure to light. Do not freeze.
-
Isotype
- IgG2a kappa
-
-
-
-
Application Notes
- This antibody preparation has been quality-tested for flow cytometry using mouse spleen cells, or an appropriate cell type (where indicated). Please refer to the figure legend for the optimal concentration used to stain the tissue shown. We recommend titrating the antibody under your specific conditions to determine the optimal concentration of antibody needed in your experimental system.
-
Comment
-
0.2 mg/mL
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 10 mM NaH2PO4, 150 mM NaCl, 0.09 % Sodium azide, 0.1 % gelatin, pH 7.2
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- 2-8°C protected from light
-
Expiry Date
- 12 months
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- CD309 (FLK1)
-
Background
- The Avas12a1 monoclonal antibody reacts with mouse CD309, also known as fetal liver kinase-1 (Flk-1) and vascular endothelial growth factor receptor 2 (VEGFR2). CD309 is a receptor protein tyrosine kinase involved in the embryonic development of vascular endothelial and hematopoietic cells.
-
Gene ID
- 16542
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-